🇺🇸 GKOS — Glaukos Corporation

Salud Compra fuerte
← Volver

Precio actual

246,70 USD

Máx. histórico

246,70

0 días

Caída desde máximo

En máximo

Rango 52 semanas

80,91 – 255,19

Variación hoy

+5,86%

Cierre anterior

233,04

Rango de hoy

235,95 – 255,19

Volumen hoy

2.074.592

Peor caída histórica

-69,57%

01/08/2019 → 20/03/2020

Recuperado en 299 días

Volatilidad anualizada ⓘ

54,28%

Información
Nombre completo
Glaukos Corporation
Divisa
USD
Mercado
NYSE
Sector
Salud
Industria
Medical Devices
Empleados
1.094
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
242,46 USD (puede no estar actualizado)
Primera cotización
25/06/2015
Precio actualizado
hace 3 horas
Sobre la empresa

Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, develops therapies for the treatment of glaucoma, corneal disorders, and retinal diseases in the United States and internationally. It offers iStent and iStent inject W micro-bypass stents designed to treat mild-to-moderate open-angle glaucoma through the restoration of the natural physiologic outflow pathways for aqueous humor. The company also provides iStent infinite indicated for use in the treatment of patients with glaucoma uncontrolled by prior medical and surgical therapy; and iDose TR, an intracameral procedural pharmaceutical therapy indicated for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension. In addition, the company develops iLink, a device used for the treatment of keratoconus without the removal of the epithelium; ILution, a platform of cream-based drug formulation applied to the outer surface of the eyelid for drop less transdermal delivery of pharmaceutically active compounds for the treatment of anterior segment eye disorders; and retinal XR platform to treat age-related macular degeneration, diabetic macular edema, retinal vein occlusion, and other posterior segment retinal diseases. It sells its products to ambulatory surgery centers, hospitals, and physician private practices through a direct sales organization, direct sales subsidiaries, and distributors. The company was formerly known as Transdx, Inc. Glaukos Corporation was incorporated in 1998 and is headquartered in Aliso Viejo, California.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
07/03/2017 44,44 44,70 43,62 44,07 -1,80% 2,43% 450.900
06/03/2017 44,28 45,57 44,00 44,88 +0,38% 3,55% 534.700
03/03/2017 46,72 47,22 44,40 44,71 -6,27% 6,04% 1.554.400
02/03/2017 51,91 52,49 47,03 47,70 +4,17% 10,52% 2.058.000
01/03/2017 45,93 46,50 44,58 45,79 +0,64% 4,18% 889.000
28/02/2017 46,62 47,50 45,41 45,50 -1,73% 4,48% 684.900
27/02/2017 46,05 46,64 45,84 46,30 +0,24% 1,74% 329.100
24/02/2017 44,62 46,32 43,50 46,19 +2,92% 6,32% 462.100
23/02/2017 46,06 46,17 44,13 44,88 -2,65% 4,42% 480.700
22/02/2017 46,27 46,82 45,60 46,10 +1,10% 2,64% 221.400
21/02/2017 45,70 46,06 44,98 45,60 -0,04% 2,36% 258.800
17/02/2017 45,49 45,75 44,90 45,62 +0,40% 1,87% 205.200
16/02/2017 45,92 46,15 45,08 45,44 -0,72% 2,33% 276.400
15/02/2017 45,98 46,43 45,60 45,77 -0,46% 1,81% 278.500
14/02/2017 44,77 46,09 44,62 45,98 +2,93% 3,28% 335.600
13/02/2017 44,86 45,24 44,62 44,67 +0,18% 1,38% 255.100
10/02/2017 45,13 45,36 44,59 44,59 -1,09% 1,70% 304.500
09/02/2017 45,50 45,72 44,97 45,08 -0,04% 1,65% 423.400
08/02/2017 44,33 45,26 43,95 45,10 +1,74% 2,96% 425.600
07/02/2017 44,08 44,63 43,60 44,33 +0,84% 2,34% 537.200
06/02/2017 43,60 44,11 42,35 43,96 +0,85% 4,04% 513.800
03/02/2017 43,00 43,77 43,00 43,59 +1,77% 1,79% 501.000
02/02/2017 41,19 42,95 41,01 42,83 +4,18% 4,71% 654.200
01/02/2017 41,35 41,44 40,82 41,11 -0,27% 1,50% 515.300
31/01/2017 38,20 41,42 38,19 41,22 +8,33% 8,46% 1.305.700
30/01/2017 38,52 38,60 37,51 38,05 -1,96% 2,84% 294.100
27/01/2017 39,14 39,33 38,58 38,81 -0,46% 1,92% 247.300
26/01/2017 39,03 39,05 38,41 38,99 +0,00% 1,64% 578.900
25/01/2017 38,80 39,21 38,55 38,99 +1,22% 1,70% 393.300
24/01/2017 38,45 38,81 37,85 38,52 +1,37% 2,50% 369.700